Published in

Annals of the Academy of Medicine, Singapore, 5(38), p. 396-401, 2009

DOI: 10.47102/annals-acadmedsg.v38n5p396

Links

Tools

Export citation

Search in Google Scholar

Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress

Journal article published in 2009 by Stephen J. Wood, Murat Yucel ORCID, Christos Pantelis ORCID, Michael Berk ORCID
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown

Abstract

Mitochondrial dysfunction and oxidative stress are increasingly implicated in the pathophysiology of schizophrenia. The brain is the body’s highest energy consumer, and the glutathione system is the brain’s dominant free radical scavenger. In the current paper, we review the evidence of central and peripheral nervous system anomalies in the oxidative defences of individuals with schizophrenia, principally involving the glutathione system. This is reflected by evidence of the manifold consequences of oxidative stress that include lipid peroxidation, protein carboxylation, DNA damage and apoptosis – all potentially part of the process of neuroprogression in the disorder. Importantly, oxidative stress is amenable to intervention. We consider the clinical potential of some possible interventions that help reduce oxidative stress, via augmentation of the glutathione system, particularly N-acetyl cysteine. We argue that a better understanding of the mechanisms and pathways underlying oxidative stress will assist in developing the therapeutic potential of this area. Key words: Glutathione, Magnetic resonance spectroscopy, N-acetyl cysteine